NCT01311024 - Indirect Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage | Biotech Hunter

Enrollment

2,341

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

December 31, 2017

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL

PCV GSK1024850A

2 to 4 doses administered to the siblings in the cluster-randomized Finnish Invasive pneumococcal Disease Trial (ClinicalTrials.gov Identifier:NCT00861380)

BIOLOGICAL

hepatitis B vaccine or hepatitis A vaccine

2 to 4 doses administered to the siblings in the cluster-randomized Finnish Invasive pneumococcal Disease Trial (ClinicalTrials.gov Identifier:NCT00861380)

Trial Locations (1)

Unknown

National Institute for Health and Welfare, Tampere